domain | bioxconomy.com |
summary | **Summary:**
- **Biopharma Market Instability:** An expert warns that the biopharma market is currently in a period of instability (Millie Nelson, Apr 29, 2025). - **Netherlands Investment in Biotech:** The Netherlands has injected €1.5 billion into biotech as part of its 2040 vision (Millie Nelson, Apr 23, 2025). - **EU Growth Strategy:** The European Union has pledged €568 million to attract scientists to the EU under its 'Choose Europe' initiative (Millie Nelson, May 7, 2025). - **Biotech Deals:** - Numab's CEO discusses how saying "no" helped the company grow from a valuation of $30 million to $1.25 billion (Millie Nelson, May 6, 2025). - Novartis and Regulus have formed an $800 million deal focused on finding a cure for kidney disease (Dan Stanton & Millie Nelson, May 5, 2025). - **Investment Challenges in Europe:** Industry experts remain optimistic about European scientific talent but express concerns about available capital (Turquoise background with light bulb and money drawings, no author or date). - **Asia Pacific Deal-Making:** BIO-Europe Spring brings together biotech and pharma leaders from around the world to advance deal-making in Asia (no author or date). - **CRISPR Revolution:** Partnerships are driving the CRISPR revolution, according to Caszyme's CEO (Jan 30, 2025). - **AltruBio CEO on Success:** AltruBio's CEO attributes success to preparation, not luck (Dec 13, 2024). - **Chiesi Partnering Strategy:** Chiesi's senior vice president shares insights into the company's successful partnering strategy (Nov 14, 2024). |
title | BioXconomy |
description | BioXconomy provides information and insights for life sciences investment, innovation and partnering. |
keywords | investment, read, nelson, europe, asia, says, biotech, strategy, eyes, netherlands, scientists, stay, sign, market, period, instability, expert |
upstreams |
|
downstreams |
|
nslookup | A 172.64.153.207, A 104.18.34.49 |
created | 2025-03-25 |
updated | 2025-05-10 |
summarized | 2025-05-10 |
|
|